Microbix Biosystems Inc. develops biological products and technologies. The Company has a Virology Products business, including the manufacturing and sale of cell culture-based biological products and the licensing of technologies. The Company has also developed VIRUSMAX (a virus yield enhancement technology), and Kinlytic (a thrombolytic drug), and is developing LumiSort a semen sexing technology. LumiSort is next generation instrument based (cytometric) technology that will improve the yield and quality of sexed semen while increasing the speed of sex-sorting by an order of magnitude over methods used in the livestock industry. Urokinase is a natural human protein that stimulates the human body�s blood clot-dissolving processes. VIRUSMAX technology is a process for recovery of more viruses from influenza virus-infected chick embryos (eggs) to enhance influenza vaccine production.